Micafungin and Liver function test abnormal - a phase IV clinical study of FDA data

Summary:

Liver function test abnormal is reported as a side effect among people who take Micafungin (micafungin sodium), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Prednisone, and have High blood pressure.

The phase IV clinical study analyzes which people have Liver function test abnormal when taking Micafungin. It is created by eHealthMe based on reports of 6,557 people who have side effects when taking Micafungin from the FDA, and is updated regularly.

What is Micafungin?

Micafungin has active ingredients of micafungin sodium. eHealthMe is studying from 6,562 Micafungin users. Check the latest studies of Micafungin.

What is Liver function test abnormal?

Liver function test abnormal is found to be associated with 1,491 drugs and 1,963 conditions by eHealthMe. Check the latest studies of Liver function test abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

6,557 people reported to have side effects when taking Micafungin.
Among them, 12 people (0.18%) have Liver function test abnormal.

Could Micafungin cause Liver function test abnormal?

Among these 12 people:

How long have people been on Micafungin when they have Liver function test abnormal? *

What is the gender of people who have Liver function test abnormal when taking Micafungin? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Liver function test abnormal when taking Micafungin? *

What are other drugs people take besides Micafungin? *

What are other side effects people have besides Liver function test abnormal? *

Abdominal Pain: 4 people, 33.33%
Blood Bilirubin Increased: 3 people, 25.00%
Fever: 2 people, 16.67%
Bleeding Disorders: 2 people, 16.67%
Abdominal Distension: 2 people, 16.67%
Abdominal Pain Upper: 2 people, 16.67%
Constipation: 2 people, 16.67%
Cytomegalovirus Infection: 2 people, 16.67%
Haemorrhoidal Haemorrhage (bleeding from the haemorrhoids): 2 people, 16.67%
Aspartate Aminotransferase Increased: 2 people, 16.67%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Wound Complication: 1 person, 8.33%
Electrolyte Imbalance: 1 person, 8.33%
Acidosis (build-up of carbon dioxide in the blood): 1 person, 8.33%
Anaemia (lack of blood): 1 person, 8.33%
Aspergillosis (an infection caused by a fungus called aspergillus): 1 person, 8.33%
Asthma: 1 person, 8.33%
Atherosclerosis (disorder of the arteries): 1 person, 8.33%
Blood Disorder: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin and have Liver function test abnormal?

- Check whether Liver function test abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micafungin:

Micafungin (6,562 reports)

Browse all side effects of Micafungin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Liver function test abnormal:

Liver function test abnormal (1,491 drugs)

Browse all the conditions that are associated with Liver function test abnormal:

Liver function test abnormal (1,963 conditions)

Related publications that referenced our studies

Cheng HI, Chen TH, Chung TC, Lee HY, Yu CY, "Micafungin-Induced Hyperbilirubinemia: A Case Report", 臺灣臨床藥學雜誌, 2014 Jun .
Cheng HI, Chen TH, Chung TC, Lee HY, Yu CY, "Micafungin-Induced Hyperbilirubinemia: A Case Report", 臺灣臨床藥學雜誌, 2014 Jun .

How the study uses the data?

The study uses data from the FDA. It is based on micafungin sodium (the active ingredients of Micafungin) and Micafungin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.